676 related articles for article (PubMed ID: 27994459)
1. The nasal delivery of nanoencapsulated statins - an approach for brain delivery.
Clementino A; Batger M; Garrastazu G; Pozzoli M; Del Favero E; Rondelli V; Gutfilen B; Barboza T; Sukkar MB; Souza SA; Cantù L; Sonvico F
Int J Nanomedicine; 2016; 11():6575-6590. PubMed ID: 27994459
[TBL] [Abstract][Full Text] [Related]
2. Structure and Fate of Nanoparticles Designed for the Nasal Delivery of Poorly Soluble Drugs.
Clementino AR; Pellegrini G; Banella S; Colombo G; Cantù L; Sonvico F; Del Favero E
Mol Pharm; 2021 Aug; 18(8):3132-3146. PubMed ID: 34259534
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
[TBL] [Abstract][Full Text] [Related]
4. Anti-Inflammatory Properties of Statin-Loaded Biodegradable Lecithin/Chitosan Nanoparticles: A Step Toward Nose-to-Brain Treatment of Neurodegenerative Diseases.
Clementino AR; Marchi C; Pozzoli M; Bernini F; Zimetti F; Sonvico F
Front Pharmacol; 2021; 12():716380. PubMed ID: 34630094
[TBL] [Abstract][Full Text] [Related]
5. Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study.
Qureshi M; Aqil M; Imam SS; Ahad A; Sultana Y
Curr Drug Deliv; 2019; 16(2):123-135. PubMed ID: 30317997
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery.
Bruinsmann FA; Pigana S; Aguirre T; Dadalt Souto G; Garrastazu Pereira G; Bianchera A; Tiozzo Fasiolo L; Colombo G; Marques M; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30781722
[TBL] [Abstract][Full Text] [Related]
7. Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine - Development & characterization in physiologically relevant 3D tissue models.
Gadhave DG; Quadros M; Ugale AR; Goyal M; Ayehunie S; Gupta V
Int J Biol Macromol; 2024 May; 267(Pt 2):131491. PubMed ID: 38599435
[TBL] [Abstract][Full Text] [Related]
8. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.
Hanafy AS; Farid RM; ElGamal SS
Drug Dev Ind Pharm; 2015; 41(12):2055-68. PubMed ID: 26133084
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of thermo-responsive nasal in situ gelling system dispersed with piribedil loaded lecithin-chitosan hybrid nanoparticles for improved brain availability.
Uppuluri CT; Ravi PR; Dalvi AV
Neuropharmacology; 2021 Dec; 201():108832. PubMed ID: 34627852
[TBL] [Abstract][Full Text] [Related]
10. Preparation of Chitosan Okra Nanoparticles: Optimization and Evaluation as Mucoadhesive Drug Delivery System.
Brar V; Kaur G
Pharm Nanotechnol; 2018; 6(3):180-191. PubMed ID: 30101724
[TBL] [Abstract][Full Text] [Related]
11. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
Shah B; Khunt D; Misra M; Padh H
Int J Biol Macromol; 2016 Aug; 89():206-18. PubMed ID: 27130654
[TBL] [Abstract][Full Text] [Related]
12. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles.
Nigam K; Kaur A; Tyagi A; Nematullah M; Khan F; Gabrani R; Dang S
Drug Deliv Transl Res; 2019 Oct; 9(5):879-890. PubMed ID: 30887226
[TBL] [Abstract][Full Text] [Related]
13. Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration.
Wen Z; Yan Z; He R; Pang Z; Guo L; Qian Y; Jiang X; Fang L
Drug Deliv; 2011 Nov; 18(8):555-61. PubMed ID: 21812752
[TBL] [Abstract][Full Text] [Related]
14. Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo.
Bruinsmann FA; de Cristo Soares Alves A; de Fraga Dias A; Lopes Silva LF; Visioli F; Raffin Pohlmann A; Figueiró F; Sonvico F; Stanisçuaski Guterres S
Int J Pharm; 2022 Mar; 616():121563. PubMed ID: 35151819
[TBL] [Abstract][Full Text] [Related]
15. A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation.
Youssef NAHA; Kassem AA; Farid RM; Ismail FA; El-Massik MAE; Boraie NA
Int J Pharm; 2018 Sep; 548(1):609-624. PubMed ID: 30033394
[TBL] [Abstract][Full Text] [Related]
16. Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity.
Raj R; Wairkar S; Sridhar V; Gaud R
Int J Biol Macromol; 2018 Apr; 109():27-35. PubMed ID: 29247729
[TBL] [Abstract][Full Text] [Related]
17. Lipid-core nanocapsules are an alternative to the pulmonary delivery and to increase the stability of statins.
Lorenzoni R; Cordenonsi LM; Davies S; Antonow MB; Medina Diedrich AS; Santos CG; Vitalis GS; Garrastazu G; Buttini F; Sonvico F; Gomes P; Raffin RP
J Microencapsul; 2019 Jun; 36(4):317-326. PubMed ID: 31159613
[No Abstract] [Full Text] [Related]
18. Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles.
Sharma D; Sharma RK; Sharma N; Gabrani R; Sharma SK; Ali J; Dang S
AAPS PharmSciTech; 2015 Oct; 16(5):1108-21. PubMed ID: 25698083
[TBL] [Abstract][Full Text] [Related]
19. Brain targeting of olanzapine via intranasal delivery of core-shell difunctional block copolymer mixed nanomicellar carriers: in vitro characterization, ex vivo estimation of nasal toxicity and in vivo biodistribution studies.
Abdelbary GA; Tadros MI
Int J Pharm; 2013 Aug; 452(1-2):300-10. PubMed ID: 23684658
[TBL] [Abstract][Full Text] [Related]
20. Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.
Jafarieh O; Md S; Ali M; Baboota S; Sahni JK; Kumari B; Bhatnagar A; Ali J
Drug Dev Ind Pharm; 2015; 41(10):1674-81. PubMed ID: 25496439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
